Interferon Gamma Suppresses Collagen-Induced Arthritis by Regulation of Th17 through the Induction of Indoleamine-2,3-Deoxygenase

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lee, Jaeseon ^a   Lee, Jennifer ^a   Park, Mi Kyung ^a   Lim, Mi Ae ^a   Park, Eun Mi ^a   Kim, Eun kyung ^a   Yang, Eun Ji ^a   Lee, Seon Yeong ^a   Jhun, Joo Yeon ^a   Park, Sung Hwan ^a   Kim, Ho Youn ^a   Cho, Mi La ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; GAMMA INTERFERON; HERMES ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 17; L SELECTIN; N METHYLTRYPTOPHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTHRITIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; ENZYME INDUCTION; GAMMA INTERFERON GENE; GENE DELETION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INTERLEUKIN 17 GENE; KNOCKOUT MOUSE; MALE; MEMORY T LYMPHOCYTE; MESENTERY LYMPH NODE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; SPLEEN CELL; TH17 CELL; WILD TYPE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CD4-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS;

EID: 84876186221     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060900     Document Type: Article

References (38)

1. Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, et al. (1997) High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol 158: 5501-5506.
2. Chu CQ, Song Z, Mayton L, Wu B, Wooley PH, (2003) IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. Ann Rheum Dis 62: 983-990.
3. Zhang HL, Azimullah S, Zheng XY, Wang XK, Amir N, et al. (2012) IFN-gamma deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response. J Neuroimmunol 246: 18-26.
4. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, et al. (1996) Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156: 5-7.
5. Wang S, Fan Y, Brunham RC, Yang X, (1999) IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur J Immunol 29: 3782-3792.
6. Murphy WJ, Welniak LA, Taub DD, Wiltrout RH, Taylor PA, et al. (1998) Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest 102: 1742-1748.
7. Guedez YB, Whittington KB, Clayton JL, Joosten LA, van de Loo FA, et al. (2001) Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum 44: 2413-2424.
8. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132.
9. Chu CQ, Swart D, Alcorn D, Tocker J, Elkon KB, (2007) Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum 56: 1145-1151.
10. Kelchtermans H, Schurgers E, Geboes L, Mitera T, Van Damme J, et al. (2009) Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma. Arthritis Res Ther 11: R122.
11. Mellor AL, Munn DH, (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762-774.
12. Munn DH, Mellor AL, (2007) Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117: 1147-1154.
13. Mellor AL, Baban B, Chandler P, Marshall B, Jhaver K, et al. (2003) Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 171: 1652-1655.
14. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, et al. (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189: 1363-1372.
15. Yadav MC, Burudi EM, Alirezaei M, Flynn CC, Watry DD, et al. (2007) IFN-gamma-induced IDO and WRS expression in microglia is differentially regulated by IL-4. Glia 55: 1385-1396.
16. Odemuyiwa SO, Ghahary A, Li Y, Puttagunta L, Lee JE, et al. (2004) Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J Immunol 173: 5909-5913.
17. Park M-K, Oh H-J, Heo Y-M, Park E-M, Cho M-L, et al. (2011) Myeloid differentiation primary response protein 88 blockade upregulates indoleamine 2,3-dioxygenase expression in rheumatoid synovial fibroblasts. Experimental and Molecular Medicine 43: 446.
18. Beutelspacher SC, Tan PH, McClure MO, Larkin DF, Lechler RI, et al. (2006) Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am J Transplant 6: 1320-1330.
19. Munn DH, (2006) Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation. Curr Opin Immunol 18: 220-225.
20. Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, et al. (2005) GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22: 633-642.
21. Curti A, Trabanelli S, Salvestrini V, Baccarani M, Lemoli RM, (2009) The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. Blood 113: 2394-2401.
22. Chen SY, Wu CL, Lai MD, Lin CC, Yo YT, et al. (2011) Amelioration of rat collagen-induced arthritis through CD4+ T cells apoptosis and synovial interleukin-17 reduction by indoleamine 2,3-dioxygenase gene therapy. Hum Gene Ther 22: 145-154.
23. Criado G, Simelyte E, Inglis JJ, Essex D, Williams RO, (2009) Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis. Arthritis Rheum 60: 1342-1351.
24. Inglis JJ, Simelyte E, McCann FE, Criado G, Williams RO, (2008) Protocol for the induction of arthritis in C57BL/6 mice. Nat Protoc 3: 612-618.
25. Chen W, (2011) IDO: more than an enzyme. Nat Immunol 12: 809-811.
26. Ikemoto T, Shimada M, Komatsu M, Yamada S, Saito Y, et al. (2013) Indoleamine 2,3-dioxygenase Affects the Aggressiveness of Intraductal Papillary Mucinous Neoplasms Through Foxp3+CD4+CD25+ T Cells in Peripheral Blood. Pancreas 42: 130-134.
27. Sun J, Yu J, Li H, Yang L, Wei F, et al. (2011) Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells. J Exp Clin Cancer Res 30: 82.
28. Wainwright DA, Balyasnikova IV, Chang AL, Ahmed AU, Moon KS, et al. (2012) IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival. Clin Cancer Res 18: 6110-6121.
29. Yan Y, Zhang GX, Gran B, Fallarino F, Yu S, et al. (2010) IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol 185: 5953-5961.
30. Schurgers E, Billiau A, Matthys P, (2011) Collagen-induced arthritis as an animal model for rheumatoid arthritis: focus on interferon-gamma. J Interferon Cytokine Res 31: 917-926.
31. Lemmel EM, Brackertz D, Franke M, Gaus W, Hartl PW, et al. (1988) Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma. Rheumatol Int 8: 87-93.
32. Takahashi N, Mundy GR, Roodman GD, (1986) Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells. J Immunol 137: 3544-3549.
33. Page CE, Smale S, Carty SM, Amos N, Lauder SN, et al. (2010) Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis. Arthritis Res Ther 12: R49.
34. Wang Z, Hong J, Sun W, Xu G, Li N, et al. (2006) Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. J Clin Invest 116: 2434-2441.
35. Sarkar S, Cooney LA, White P, Dunlop DB, Endres J, et al. (2009) Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4. Arthritis Res Ther 11: R158.
36. Irmler IM, Gajda M, Brauer R, (2007) Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J Immunol 179: 6228-6236.
37. Yang XP, Ghoreschi K, Steward-Tharp SM, Rodriguez-Canales J, Zhu J, et al. (2011) Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat Immunol 12: 247-254.
38. Schroecksnadel K, Winkler C, Duftner C, Wirleitner B, Schirmer M, et al. (2006) Tryptophan degradation increases with stage in patients with rheumatoid arthritis. Clin Rheumatol 25: 334-337.